Stocks · Health care · Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST Clue Score18
United States Fiscal year ends December CIK 0001398733 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Cassie Jung
10 Mar 2026
Chief Operating Officer
Sell
45,791
$4.17
$191.09K
Sherry Korczynski
10 Mar 2026
Chief Commercial Officer
Sell
15,741
$4.17
$65.69K
A Ernest Toth Jr
10 Mar 2026
Chief Financial Officer
Sell
58,254
$4.17
$243.09K
Melina Cioffi
10 Mar 2026
SVP, Regulatory Affairs
Sell
25,311
$4.17
$105.62K
Lori J Braender
10 Mar 2026
Chief Legal Officer
Sell
40,102
$4.17
$167.35K
Daniel Barber
10 Mar 2026
President and CEO
Sell
180,677
$4.17
$753.97K
Peter E. Boyd
10 Mar 2026
Chief People Officer
Sell
29,814
$4.17
$124.41K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 2
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 2,040,703
History held since 26 Jul 2018